secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2023-01-04T23:59:59+00:00
Accession:  0001493152-23-000368
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio closes $2.5M registered direct offering and concurrent private placement
--------------------------------------------------------------------------------

- Raised approximately $2.5M gross via 1,052,631 shares/pre-funded warrants at $2.375/share plus 1,052,631 five-year warrants at $2.375.
- Transaction closed January 4, 2023; Ladenburg Thalmann acted as exclusive placement agent.
- Proceeds intended for working capital and general corporate purposes.
- Offering includes registered direct (513,842 shares/pre-funded warrants) and unregistered private placement (538,789 pre-funded warrants).
- Company agreed to file resale registration statement for underlying shares within 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315223000368/0001493152-23-000368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315223000368/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-000368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer